OneAnswer Australasian Share

Fisher & Paykel Healthcare makes up more than 15% of this fund, a concentration that puts the medical device maker at the centre of the portfolio and leaves investors heavily exposed to a single company's fortunes.

ANZ Investments runs this as an all-equity fund, with 99.66% in Australasian shares and the remainder in cash. The top ten holdings account for 68% of the total, dominated by New Zealand names: Infratil, Auckland Airport, Contact Energy, and Mainfreight follow Fisher & Paykel at the top. Australian exposure, if present, sits further down the list. The fund charges a total fee of 1.02% annually, comprising a 0.95% management fee and 0.04% in other costs, with no performance fee. At $33.3 million in assets under management, this is a small fund by sector standards.

Over five years, it returned 1.2% per annum, a modest figure for a high-growth equity fund. The one-year return of 2.5% and three-year return of 6.5% show more recent volatility. With a risk level of 6, the fund sits at the higher end of the scale, reflecting its full allocation to shares and its concentrated bets on individual stocks.

General information only, not financial advice. Past performance is not a reliable indicator of future results.